WebMay 1, 2024 · It was observed that DGCR5 was upregulated in LUAD tissues and LUAD cell lines, implying a favorable prognosis of LUAD patients and a novel microRNA target, hsa‐mir‐22‐3p, which could be considered as a prognostic biomarker and therapeutic target inLUAD diagnosis and treatment. Long non‐coding RNAs (lncRNAs) serve critical roles in … WebMay 23, 2024 · Mutant DGCR5 (pmirGLO‐DGCR5‐MUT) was generated by site‐directed mutagenesis PCR with platinum pfx DNA polymerase according to the product manual and served as negative control. Luciferase reporter plasmids and target miR‐873‐5p mimics or miR‐NC mimics were cotransfected into cells by Lipofectamine 2000.
DGCR5 induces osteogenic differentiation by up ... - ScienceDirect
WebDec 23, 2024 · It has been reported that DGCR5 can regulate the proliferation of lung cancer cells. 11 This study is the first to report the regulatory role of DGCR5 in cancer cell stemness. Therefore, regulating the expression of DGCR5 may serve as a target to treat PC by suppressing cancer stemness. WebJan 1, 2024 · Long noncoding RNA DiGeorge syndrome critical region gene 5 (DGCR5) has been shown to be highly associated with cancer development. However, the biological … foil an evil plan say crossword clue
Frontiers LncRNA DGCR5 Isoform-1 Silencing Suppresses the …
WebLong noncoding RNA DiGeorge syndrome critical region gene 5 (DGCR5) has been shown to be highly associated with cancer development. However, the biological role and molecular mechanism of DGCR5... In molecular biology, DiGeorge syndrome critical region gene 5 (non-protein coding), also known as DGCR5, is a long non-coding RNA. In humans, it is located on chromosome 22q11, at the ADU breakpoint associated with DiGeorge syndrome. Its expression is regulated by the transcription factor REST (RE1-Silencing Transcription factor). WebHuman Gene DGCR5 (uc021wku.1) Description: Homo sapiens DiGeorge syndrome critical region gene 5 (non-protein coding) (DGCR5), transcript variant 1, non-coding RNA. … foil and lighter